Trailing-twelve-month (TTM) net income is ($7.40 Billion) A growth comparison is not meaningful when a comparison period reports a loss.. Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-30): $-1.33B.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:00.000Z. Historical observations retain their original dates. Historical series through 2026-02-10.
($7.40B)
($7.40 Billion)
n/m
A growth comparison is not meaningful when a comparison period reports a loss.
(19.47%)
3 Year compound annual growth rate
1 Year
(334.72%)
3 Year
(19.47%)
5 Year
N/A
10 Year
(1.65%)
15 Year
(2.85%)
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2025 | ($8.18B) | ($14.06B) | (239.17%) |
| 2024 | $5.88B | +$1.53B | +35.24% |
| 2023 | $4.35B | +$6.33B | N/A |
| 2022 | ($1.98B) | ($19.92B) | (111.04%) |
| 2021 | $17.94B | +$19.22B | N/A |
| 2020 |
TTM Growth
n/m
3-Year CAGR
n/m
5-Year CAGR
n/m
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-09T20:00:00.000Z. Historical observations retain their original dates. Historical series through 2026-02-10.
| ($1.28B) |
| ($1.33B) |
| (2821.28%) |
| 2019 | $47.00M | ($3.63B) | (98.72%) |
| 2018 | $3.68B | ($4.05B) | (52.44%) |
| 2017 | $7.73B | +$3.13B | +68.21% |
| 2016 | $4.60B | ($2.78B) | (37.66%) |
